I Gde Sastra Winata, Leonardo Leonardo, Rosalia Sylfiasari, Angeline Ekafentie, Surya Sinaga Immanuel, Fenyta Christyani
Background: The global resurgence of mpox, formerly monkeypox, poses an emerging threat to pregnant women due to immunological changes and potential vertical transmission, yet its impact on pregnancy remains underexplored. This study aims to pioneer a comprehensive assessment of pregnancy outcomes and the risks of vertical transmission associated with mpox infection during pregnancy.
Materials and methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched three databases up to September 2024 for studies on pregnant women with mpox confirmed by quantitative polymerase chain reaction. Primary outcomes were composite adverse pregnancy outcomes: miscarriage or fetal death, congenital anomalies, and chorioamnionitis; the secondary outcome was vertical transmission. Study quality was assessed using Joanna Briggs Institute tools. Statistical analysis employed R software using a one-proportion model with Freeman-Tukey transformation and random-effects meta-analysis (restricted maximum-likelihood estimator, Knapp-Hartung adjustment), presenting estimated proportions with 95% confidence intervals (CIs).
Results: Six studies (three case series, three case reports) comprising 11 singleton pregnancies were included. Diagnoses occurred in the first (27.3%), second (45.4%), and third trimesters (27.3%). Among the five genotypically identified Mpox cases, 20.0% were classified Clade I and 80.0% as Clade II. Meta-analysis indicated that an estimated 63% (95% CI, 43-83%) of pregnancies experienced composite adverse pregnancy outcomes. Specifically, miscarriage or fetal death occurred in 62% (95% CI, 21-102%), congenital anomalies in 50% (95% CI, 21-80%), and chorioamnionitis in 78% (95% CI, 44-96%). Vertical transmission was observed in 79% (95% CI, 6-151%). Despite small sample sizes leading to wide confidence intervals, high estimated proportions suggest that mpox severely impacts pregnancy outcomes, likely linked to maternal inflammation, placental invasion, and significant fetal risks from vertical transmission.
Conclusion: Mpox infection during pregnancy appears to be associated with high rates of adverse pregnancy outcomes and vertical transmission. Further large-scale studies are warranted to confirm these findings and develop preventive and management strategies mitigating this emerging threat.
{"title":"Unveiling the Outcomes of Mpox in Pregnancy: A Systematic Review and Single-Arm Meta-Analysis.","authors":"I Gde Sastra Winata, Leonardo Leonardo, Rosalia Sylfiasari, Angeline Ekafentie, Surya Sinaga Immanuel, Fenyta Christyani","doi":"10.3947/ic.2024.0120","DOIUrl":"10.3947/ic.2024.0120","url":null,"abstract":"<p><strong>Background: </strong>The global resurgence of mpox, formerly monkeypox, poses an emerging threat to pregnant women due to immunological changes and potential vertical transmission, yet its impact on pregnancy remains underexplored. This study aims to pioneer a comprehensive assessment of pregnancy outcomes and the risks of vertical transmission associated with mpox infection during pregnancy.</p><p><strong>Materials and methods: </strong>Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched three databases up to September 2024 for studies on pregnant women with mpox confirmed by quantitative polymerase chain reaction. Primary outcomes were composite adverse pregnancy outcomes: miscarriage or fetal death, congenital anomalies, and chorioamnionitis; the secondary outcome was vertical transmission. Study quality was assessed using Joanna Briggs Institute tools. Statistical analysis employed R software using a one-proportion model with Freeman-Tukey transformation and random-effects meta-analysis (restricted maximum-likelihood estimator, Knapp-Hartung adjustment), presenting estimated proportions with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Six studies (three case series, three case reports) comprising 11 singleton pregnancies were included. Diagnoses occurred in the first (27.3%), second (45.4%), and third trimesters (27.3%). Among the five genotypically identified Mpox cases, 20.0% were classified Clade I and 80.0% as Clade II. Meta-analysis indicated that an estimated 63% (95% CI, 43-83%) of pregnancies experienced composite adverse pregnancy outcomes. Specifically, miscarriage or fetal death occurred in 62% (95% CI, 21-102%), congenital anomalies in 50% (95% CI, 21-80%), and chorioamnionitis in 78% (95% CI, 44-96%). Vertical transmission was observed in 79% (95% CI, 6-151%). Despite small sample sizes leading to wide confidence intervals, high estimated proportions suggest that mpox severely impacts pregnancy outcomes, likely linked to maternal inflammation, placental invasion, and significant fetal risks from vertical transmission.</p><p><strong>Conclusion: </strong>Mpox infection during pregnancy appears to be associated with high rates of adverse pregnancy outcomes and vertical transmission. Further large-scale studies are warranted to confirm these findings and develop preventive and management strategies mitigating this emerging threat.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"119-130"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Josef Finsterer, Carla Alexandra Scorza, Fulvio Alexandre Scorza, Ana Claudia Fiorini
{"title":"Food, Water, Air, and Mind must Become Cleaner.","authors":"Josef Finsterer, Carla Alexandra Scorza, Fulvio Alexandre Scorza, Ana Claudia Fiorini","doi":"10.3947/ic.2024.0136","DOIUrl":"10.3947/ic.2024.0136","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"181-182"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Simbiat Tolani Lawal, Fadilulahi Ayokunle Usman, Zainab Adepeju Adams, Omoladun Safurat Ogunbayo, Chioma Margaret Ekwedigwe, Rukayat Olajumoke Jimoh, Fortunate Opeyemi Oladeru, Oyindamola Osho, Utibeima Udo Essiet, Abraham Ajayi, Stella Smith
Background: Antimicrobial resistance has emerged as a global public health challenge, leading to higher mortality rates from infections that were once treatable with antibiotics. In this study, we assessed the susceptibility of Escherichia coli strains isolated from clinical samples to carbapenems and fluoroquinolones and screened for genetic determinants mediating resistance.
Materials and methods: This retrospective study included 46 E. coli isolates retrieved from the stock culture collection at the Molecular Biology and Biotechnology Department of the Nigerian Institute of Medical Research. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method, and molecular techniques were employed to detect genetic determinants of antimicrobial resistance.
Results: The E. coli isolates exhibited high resistance to fluoroquinolones, with 72% resistant to ciprofloxacin and 52% to levofloxacin. Resistance to carbapenems was relatively low, with 4% resistant to imipenem and 11% to meropenem. The prevalence of the genetic determinants gyrA, gyrB, and parC, which mediate fluoroquinolone resistance, was 26%, 24%, and 15%, respectively. blaOXA-48 and blaNDM, which mediate carbapenem resistance, were detected in only two isolates. Some isolates harbored plasmids ranging from 5 kb to 16 kb; however, no plasmid-mediated genetic determinants conferring fluoroquinolone resistance were identified.
Conclusion: This study revealed a high level of resistance to fluoroquinolones, emphasizing the need for judicious use of antibiotics, particularly those with low resistance rates. Continuous surveillance is essential to monitor emerging trends in resistance among bacterial pathogens.
{"title":"Genetic Determinants of Carbapenem and Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolates of Clinical Origin.","authors":"Simbiat Tolani Lawal, Fadilulahi Ayokunle Usman, Zainab Adepeju Adams, Omoladun Safurat Ogunbayo, Chioma Margaret Ekwedigwe, Rukayat Olajumoke Jimoh, Fortunate Opeyemi Oladeru, Oyindamola Osho, Utibeima Udo Essiet, Abraham Ajayi, Stella Smith","doi":"10.3947/ic.2024.0108","DOIUrl":"10.3947/ic.2024.0108","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance has emerged as a global public health challenge, leading to higher mortality rates from infections that were once treatable with antibiotics. In this study, we assessed the susceptibility of <i>Escherichia coli</i> strains isolated from clinical samples to carbapenems and fluoroquinolones and screened for genetic determinants mediating resistance.</p><p><strong>Materials and methods: </strong>This retrospective study included 46 <i>E. coli</i> isolates retrieved from the stock culture collection at the Molecular Biology and Biotechnology Department of the Nigerian Institute of Medical Research. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method, and molecular techniques were employed to detect genetic determinants of antimicrobial resistance.</p><p><strong>Results: </strong>The <i>E. coli</i> isolates exhibited high resistance to fluoroquinolones, with 72% resistant to ciprofloxacin and 52% to levofloxacin. Resistance to carbapenems was relatively low, with 4% resistant to imipenem and 11% to meropenem. The prevalence of the genetic determinants <i>gyrA</i>, <i>gyrB</i>, and <i>parC</i>, which mediate fluoroquinolone resistance, was 26%, 24%, and 15%, respectively. <i>bla</i><sub>OXA-48</sub> and <i>bla</i><sub>NDM</sub>, which mediate carbapenem resistance, were detected in only two isolates. Some isolates harbored plasmids ranging from 5 kb to 16 kb; however, no plasmid-mediated genetic determinants conferring fluoroquinolone resistance were identified.</p><p><strong>Conclusion: </strong>This study revealed a high level of resistance to fluoroquinolones, emphasizing the need for judicious use of antibiotics, particularly those with low resistance rates. Continuous surveillance is essential to monitor emerging trends in resistance among bacterial pathogens.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"102-110"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-01Epub Date: 2025-01-22DOI: 10.3947/ic.2024.0131
Hyeon Mu Jang, Han-Seung Park, Heungsup Sung, Sung-Han Kim
We report a case of cytomegalovirus retinitis in a hematopoietic stem cell transplant recipient during valganciclovir pre-emptive therapy followed by maribavir. Analysis of UL97 mutation revealed a C480F substitution associated with high maribavir resistance and low ganciclovir resistance.
{"title":"Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy.","authors":"Hyeon Mu Jang, Han-Seung Park, Heungsup Sung, Sung-Han Kim","doi":"10.3947/ic.2024.0131","DOIUrl":"10.3947/ic.2024.0131","url":null,"abstract":"<p><p>We report a case of cytomegalovirus retinitis in a hematopoietic stem cell transplant recipient during valganciclovir pre-emptive therapy followed by maribavir. Analysis of UL97 mutation revealed a C480F substitution associated with high maribavir resistance and low ganciclovir resistance.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"168-171"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Understanding and Addressing Long COVID, the Lingering Shadow of COVID-19.","authors":"Jung Wan Park","doi":"10.3947/ic.2025.0025","DOIUrl":"10.3947/ic.2025.0025","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"179-180"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-30DOI: 10.3947/ic.2024.0045
Pirun Saelue, Thitichaya Penthinapong
Background: In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.
Materials and methods: Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.
Results: With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.
Conclusion: Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.
{"title":"Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events.","authors":"Pirun Saelue, Thitichaya Penthinapong","doi":"10.3947/ic.2024.0045","DOIUrl":"10.3947/ic.2024.0045","url":null,"abstract":"<p><strong>Background: </strong>In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.</p><p><strong>Materials and methods: </strong>Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.</p><p><strong>Results: </strong>With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.</p><p><strong>Conclusion: </strong>Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"483-491"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Evangelia Iliaki-Giannakoudaki, Dimitra Stafylaki
<p><strong>Background: </strong>Lower respiratory tract infections (LRTIs) are the most common infections in humans accounting for significant morbidity and mortality. Management of LRTIs is complicated due to increasing antimicrobial resistance. This study investigated the prevalence and trends of antimicrobial resistance for bacteria isolated from respiratory samples of patients with LRTIs.</p><p><strong>Materials and methods: </strong>Sputum and bronchial washings were collected from patients of all ages hospitalized with LRTIs and were analyzed by the microbiological laboratory in the University Hospital of Heraklion, Crete, Greece, from January 2017 to December 2022. Identification of the bacterial isolates was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and antimicrobial susceptibility testing by Vitek 2 system.</p><p><strong>Results: </strong>A total of 4,008 strains were isolated from 3,427 respiratory samples. <i>Acinetobacter baumannii</i> was the most frequently isolated pathogen (23.1%), followed by <i>Pseudomonas aeruginosa</i> (20.0%), <i>Staphylococcus aureus</i> (10.6%) and <i>Klebsiella pneumoniae</i> (6.8%). The isolation rate of <i>A. baumannii</i> significantly increased during the study period, while there were lower increases in the isolation rates of <i>P. aeruginosa</i>, <i>K. pneumoniae</i> and <i>S. aureus. A. baumannii</i> and <i>P. aeruginosa</i> were more prevalent during summer, <i>K. pneumoniae</i> was more common during autumn, while for <i>S. aureus</i> higher incidence was noted during winter. <i>A. baumannii</i> exhibited high resistance rates (≥90.0%) to most of the antimicrobial agents tested, and extremely high multidrug-resistance (91.0%). <i>P. aeruginosa</i> showed the lowest rate of resistance for colistin (1.4%). Among β-lactams, resistance rates to piperacillin/tazobactam, ceftazidime, cefepime, imipenem and meropenem were 26.2%, 27%, 25.8%, 29.2% and 29.9%, respectively. A total of 162 (68.1%) meropenem-resistant <i>P. aeruginosa</i> were simultaneously resistant to ceftazidime and piperacillin/tazobactam. Regarding <i>K. pneumoniae</i>, high rates of resistance were observed for the third and fourth generation cephalosporins, namely cefotaxime, ceftriaxone, ceftazidime, and cefepime and the carbapenems, imipenem and meropenem ranging from 46.2% to 53.8%. Carbapenem-resistance was detected among 46.2% of the isolates. Among the 126 carbapenem-resistant <i>K. pneumoniae</i> isolates, 83 (65.9%), 30 (23.8%), 9 (7.2%), and 4 (4.2%) were positive for <i>Klebsiella pneumoniae</i> carbapenemase, New Delhi Metallo-β-lactamase, Verona Integron-Mediated Metallo-β-lactamase and OXA-48 carbapenemase, respectively. Of the total number of <i>S. aureus</i>, 37.2% were methicillin resistant. Low rates of resistance were detected in trimethoprim/sulfamethoxazole (3.3%), gentamicin (2.8%), and rifampicin (0.9%). All isolates were susceptible to linezolid, daptomycin, tigecy
{"title":"Prevalence and Antimicrobial Resistance Trends among Lower Respiratory Tract Pathogens in Crete, Greece, 2017-2022.","authors":"Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Evangelia Iliaki-Giannakoudaki, Dimitra Stafylaki","doi":"10.3947/ic.2024.0060","DOIUrl":"https://doi.org/10.3947/ic.2024.0060","url":null,"abstract":"<p><strong>Background: </strong>Lower respiratory tract infections (LRTIs) are the most common infections in humans accounting for significant morbidity and mortality. Management of LRTIs is complicated due to increasing antimicrobial resistance. This study investigated the prevalence and trends of antimicrobial resistance for bacteria isolated from respiratory samples of patients with LRTIs.</p><p><strong>Materials and methods: </strong>Sputum and bronchial washings were collected from patients of all ages hospitalized with LRTIs and were analyzed by the microbiological laboratory in the University Hospital of Heraklion, Crete, Greece, from January 2017 to December 2022. Identification of the bacterial isolates was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and antimicrobial susceptibility testing by Vitek 2 system.</p><p><strong>Results: </strong>A total of 4,008 strains were isolated from 3,427 respiratory samples. <i>Acinetobacter baumannii</i> was the most frequently isolated pathogen (23.1%), followed by <i>Pseudomonas aeruginosa</i> (20.0%), <i>Staphylococcus aureus</i> (10.6%) and <i>Klebsiella pneumoniae</i> (6.8%). The isolation rate of <i>A. baumannii</i> significantly increased during the study period, while there were lower increases in the isolation rates of <i>P. aeruginosa</i>, <i>K. pneumoniae</i> and <i>S. aureus. A. baumannii</i> and <i>P. aeruginosa</i> were more prevalent during summer, <i>K. pneumoniae</i> was more common during autumn, while for <i>S. aureus</i> higher incidence was noted during winter. <i>A. baumannii</i> exhibited high resistance rates (≥90.0%) to most of the antimicrobial agents tested, and extremely high multidrug-resistance (91.0%). <i>P. aeruginosa</i> showed the lowest rate of resistance for colistin (1.4%). Among β-lactams, resistance rates to piperacillin/tazobactam, ceftazidime, cefepime, imipenem and meropenem were 26.2%, 27%, 25.8%, 29.2% and 29.9%, respectively. A total of 162 (68.1%) meropenem-resistant <i>P. aeruginosa</i> were simultaneously resistant to ceftazidime and piperacillin/tazobactam. Regarding <i>K. pneumoniae</i>, high rates of resistance were observed for the third and fourth generation cephalosporins, namely cefotaxime, ceftriaxone, ceftazidime, and cefepime and the carbapenems, imipenem and meropenem ranging from 46.2% to 53.8%. Carbapenem-resistance was detected among 46.2% of the isolates. Among the 126 carbapenem-resistant <i>K. pneumoniae</i> isolates, 83 (65.9%), 30 (23.8%), 9 (7.2%), and 4 (4.2%) were positive for <i>Klebsiella pneumoniae</i> carbapenemase, New Delhi Metallo-β-lactamase, Verona Integron-Mediated Metallo-β-lactamase and OXA-48 carbapenemase, respectively. Of the total number of <i>S. aureus</i>, 37.2% were methicillin resistant. Low rates of resistance were detected in trimethoprim/sulfamethoxazole (3.3%), gentamicin (2.8%), and rifampicin (0.9%). All isolates were susceptible to linezolid, daptomycin, tigecy","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"492-501"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-08DOI: 10.3947/ic.2024.0070
Eric Fu, Ozdemir Erdemir, Khalil Pathan, Meaghan Brophy, Aidan Pettit
Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.
{"title":"A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns.","authors":"Eric Fu, Ozdemir Erdemir, Khalil Pathan, Meaghan Brophy, Aidan Pettit","doi":"10.3947/ic.2024.0070","DOIUrl":"10.3947/ic.2024.0070","url":null,"abstract":"<p><p>Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"432-439"},"PeriodicalIF":2.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated?","authors":"Josef Finsterer","doi":"10.3947/ic.2024.0115","DOIUrl":"https://doi.org/10.3947/ic.2024.0115","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"559-560"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Wound infections significantly impact morbidity, mortality, and healthcare costs globally. The Kashmir Valley's unique geographical and climatic conditions, coupled with resource constraints and antibiotic misuse, complicate managing these infections effectively. This study aimed to identify predominant bacterial pathogens in wound infections at a tertiary care hospital in Kashmir, determine their antibiotic susceptibility profiles, and estimate the prevalence of multidrug-resistant (MDR) strains.
Materials and methods: A prospective cross-sectional study was conducted from January to June 2023 at the Government Medical College, Srinagar. Pus samples from wound infections were aseptically collected and processed following standard microbiological protocols. Antibiotic susceptibility testing utilized the Kirby-Bauer disk diffusion method, adhering to Clinical and Laboratory Standards Institute guidelines. Data were analyzed using IBM SPSS statistics.
Results: Out of 4,378 samples analyzed, bacterial growth was observed in 1,921 samples, representing 43.9% of the total. Among the bacterial isolates, Gram-negative bacilli accounted for 73.5%, with Escherichia coli being the most prevalent at 27.9%. Among Gram-positive cocci, Staphylococcus aureus predominated, comprising 25.9% of the isolates. Methicillin-resistant S. aureus exhibited 100% susceptibility to linezolid but low susceptibility to erythromycin (27.0%) and clindamycin (24.0%). E. coli demonstrated high susceptibility to tigecycline (97.4%) and amikacin (75.0%), but lower susceptibility to imipenem (45.0%) and piperacillin-tazobactam (57.8%).
Conclusion: The substantial wound infection burden and high MDR prevalence in Kashmir necessitate comprehensive antimicrobial stewardship and infection control programs. Regular surveillance, education, and research are crucial to address antibiotic resistance and ensure effective wound infection management in the region.
{"title":"Prevalence and Antimicrobial Susceptibility of Wound Pathogens in a Tertiary Care Hospital in Kashmir: A Cross-sectional Study.","authors":"Tabeen Mansoor, Dekyong Angmo, Nahid Nehvi","doi":"10.3947/ic.2024.0083","DOIUrl":"https://doi.org/10.3947/ic.2024.0083","url":null,"abstract":"<p><strong>Background: </strong>Wound infections significantly impact morbidity, mortality, and healthcare costs globally. The Kashmir Valley's unique geographical and climatic conditions, coupled with resource constraints and antibiotic misuse, complicate managing these infections effectively. This study aimed to identify predominant bacterial pathogens in wound infections at a tertiary care hospital in Kashmir, determine their antibiotic susceptibility profiles, and estimate the prevalence of multidrug-resistant (MDR) strains.</p><p><strong>Materials and methods: </strong>A prospective cross-sectional study was conducted from January to June 2023 at the Government Medical College, Srinagar. Pus samples from wound infections were aseptically collected and processed following standard microbiological protocols. Antibiotic susceptibility testing utilized the Kirby-Bauer disk diffusion method, adhering to Clinical and Laboratory Standards Institute guidelines. Data were analyzed using IBM SPSS statistics.</p><p><strong>Results: </strong>Out of 4,378 samples analyzed, bacterial growth was observed in 1,921 samples, representing 43.9% of the total. Among the bacterial isolates, Gram-negative bacilli accounted for 73.5%, with <i>Escherichia coli</i> being the most prevalent at 27.9%. Among Gram-positive cocci, <i>Staphylococcus aureus</i> predominated, comprising 25.9% of the isolates. Methicillin-resistant <i>S. aureus</i> exhibited 100% susceptibility to linezolid but low susceptibility to erythromycin (27.0%) and clindamycin (24.0%). <i>E. coli</i> demonstrated high susceptibility to tigecycline (97.4%) and amikacin (75.0%), but lower susceptibility to imipenem (45.0%) and piperacillin-tazobactam (57.8%).</p><p><strong>Conclusion: </strong>The substantial wound infection burden and high MDR prevalence in Kashmir necessitate comprehensive antimicrobial stewardship and infection control programs. Regular surveillance, education, and research are crucial to address antibiotic resistance and ensure effective wound infection management in the region.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"502-509"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}